Published in Cancer Weekly, December 8th, 1997
Because this kind of an immune response is key to vaccine development, the findings have profound implications for developing safe vaccines to immunize against AIDS and other infectious diseases, and for creating new cancer therapies.
Results from the study, led by Dr. Richard Young, Whitehead Institute for Biomedical Research, were published in the November 25, 1997, issue of the Proceedings of the National Academy of Sciences...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.